Brise Pharmaceuticals Announces Global License Agreement with AbbVie to Advance the Next-Generation of Migraine Therapies BEIJING, Nov. 2, 2026 /PRNewswire/ — Brise Pharmaceuticals Co., Ltd. (Brise) today… CISION PRNewswireNovember 2, 2026
Press Release DREAM PAIRS KIDS Brings Holiday Style to Every Step with Its 2026 Seasonal Footwear Collection From statement-making Western boots and cozy winter essentials to glittery rain boots,… CISION PRNewswireNovember 2, 2026
Press Release Neurophet and RapidAI Partner to Expand Access to Alzheimer's and MS Treatment Monitoring – Agreement expands Neurophet’s reach into U.S. health systems and builds on… CISION PRNewswireNovember 2, 2026
Mobileum Receives Frost & Sullivan's 2026 Global Roaming Services Enabling Technology Leadership Recognition for Intelligence-Driven Roaming Innovation Mobileum is recognized for its unified, AI-enabled roaming platform, technology-agnostic approach, and… CISION PRNewswireNovember 2, 2026
Press Release HONBAY Expands Modular Sleeper Sectional Lineup with Altus, Vora and Cala for Flexible Family Living ONTARIO, Calif., Nov. 2, 2026 /PRNewswire/ — HONBAY, a modular sofa and sleeper… CISION PRNewswireNovember 2, 2026
Press Release Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 6.06 Million Tokens, and Total Crypto and Total Cash & Marketable Securities Holdings of $14.5 Billion Bitmine owns 4.9% of the total ETH coin supply of 122.2 million Bitmine… CISION PRNewswireNovember 2, 2026
Ractigen Therapeutics Kicks Off Multi-Center Phase II Clinical Trial of First-in-Class saRNA Therapeutic RAG-01 for Non-Muscle Invasive Bladder Cancer Trial initiated at Fudan University Shanghai Cancer Center (FUSCC) under the leadership… CISION PRNewswireNovember 2, 2026
Cell Impact to evaluate NC titanium for undisclosed customers KARLSKOGA, Sweden, Nov. 2, 2026 /PRNewswire/ — Cell Impact AB (publ) will… CISION PRNewswireNovember 2, 2026
